Insider trades
Eliana Clark, Chief Officer of Intellia Therapeutics NTLA, has filed 0 purchases and 15 sales on the open market. Over the past 12 months that comes to a net sale of $96K. The latest trade was on 03/02.
Eliana Clark
EVP, Chief Technical Officer
- Company
- Intellia Therapeutics NTLA
- First filing
- 23/01/06
- Trades
- 26 trades
- Buys / sales
- 0 / 15
- 12-month net buying
- −$96K
- Last trade
- 03/02
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale | 03/02 | 03/03 | 607 sh | $13.78 | $8,364.46 | −0.6% | |
| Open-market sale | 01/05 | 01/07 | 9,515 sh | $9.21 | $87,633.15 | −9.8% | |
| Open-market sale | 25/07/01 | 25/07/03 | 1,022 sh | $9.82 | $10,036.04 | −1.1% | |
| Open-market sale | 25/03/04 | 25/03/04 | 679 sh | $8.99 | $6,104.21 | −0.7% | |
NTLA | Open-market sale | 25/01/02–25/01/03 | 25/01/06 | 7,978 sh2 trades | $12.17avg. | $97,088.64 | −11.1% |
| Open-market sale | 24/07/01 | 24/07/03 | 405 sh | $22.93 | $9,286.65 | −0.6% | |
| Open-market sale | 24/03/04 | 24/03/05 | 605 sh | $32.99 | $19,958.95 | −0.8% | |
NTLA | Open-market sale | 24/01/03 | 24/01/05 | 4,608 sh2 trades | $29.50avg. | $135,954.3 | −10.1% |
| Open-market sale | 23/07/03 | 23/07/06 | 360 sh | $40.51 | $14,583.6 | −0.8% | |
| Open-market sale10b5-1 plan | 23/06/20 | 23/06/22 | 5,000 sh | $45.00 | $225,000 | −10.0% | |
NTLA | Open-market sale | 22/07/01–23/01/04 | 23/01/06 | 2,028 sh3 trades | $37.65avg. | $76,356.9 | −12.3% |